NCT04496466View on ClinicalTrials.gov

Clinical Characterization Protocol for Severe Infectious Diseases (CCPSEI)

CompletedOBSERVATIONAL
Enrollment

702

Participants

Timeline

Start Date

April 9, 2020

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
Coronavirus
Trial Locations (1)

21217

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT04496466 - Clinical Characterization Protocol for Severe Infectious Diseases (CCPSEI) | Biotech Hunter | Biotech Hunter